Clinical features and outcomes of bacteremia caused by Enterococcus casseliflavus and Enterococcus gallinarum:: Analysis of 56 cases

被引:65
作者
Choi, SH
Lee, SO
Kim, TH
Chung, JW
Choo, EJ
Kwak, YG
Kim, MN
Kim, YS
Woo, JH
Ryu, J
Kim, NJ
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Div Infect Dis, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul 138736, South Korea
[3] Univ Ulsan, Ctr Antimicrobial Resistance & Microbial Genet, Seoul, South Korea
关键词
D O I
10.1086/380452
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The clinical significance and virulence potential of Enterococcus casseliflavus/ flavescens and Enterococcus gallinarum are still uncertain. We retrospectively analyzed 56 cases of significant bacteremia caused by E. casseliflavus or E. gallinarum. Of these cases, 25 ( 44.6%) were associated with polymicrobial bacteremia, and 43 ( 76.8%) were associated with entry via the biliary tract. Resistance to vancomycin was observed in 17 ( 30.4%) of these 56 patients, and this resistance was significantly associated with E. gallinarum bacteremia ( adjusted odds ratio [ AOR], 10.56; 95% confidence interval [ CI], 2.41 - 46.27) and bacteremia without biliary tract origin ( AOR, 6.74; 95% CI, 1.44 - 31.67). The crude mortality rate was 13%, and the bacteremia- related mortality rate was 1.9%. In conclusion, bacteremia due to E. casseliflavus and E. gallinarum is commonly associated with biliary tract disease and may be associated with a low risk of mortality.
引用
收藏
页码:53 / 61
页数:9
相关论文
共 55 条
[51]   Selective isolation of vancomycin-resistant enterococci [J].
VanHorn, KG ;
Gedris, CA ;
Rodney, KM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) :924-927
[52]   Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis [J].
Vergis, EN ;
Shankar, N ;
Chow, JW ;
Hayden, MK ;
Snydman, DR ;
Zervos, MJ ;
Linden, PK ;
Wagener, MM ;
Muder, RR .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (05) :570-575
[53]   Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia - A prospective multicenter study [J].
Vergis, EN ;
Hayden, MK ;
Chow, JW ;
Snydman, DR ;
Zervos, MJ ;
Linden, PK ;
Wagener, MM ;
Schmitt, B ;
Muder, RR .
ANNALS OF INTERNAL MEDICINE, 2001, 135 (07) :484-492
[54]   VANCOMYCIN SUSCEPTIBILITY AND IDENTIFICATION OF MOTILE ENTEROCOCCI [J].
VINCENT, S ;
KNIGHT, RG ;
GREEN, M ;
SAHM, DF ;
SHLAES, DM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (10) :2335-2337
[55]   Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci [J].
Zaas, AK ;
Song, XY ;
Tucker, P ;
Perl, TM .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (10) :1139-1146